Home LiteratureArticle Details
PMID: 16417656 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells.

Breast cancer research : BCR ·Vol. 8 ·No. 1 ·2006-00-00 ·Pages R7

Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ

Abstract

Breast cancer is thought to arise in mammary epithelial stem cells. There is, therefore, a large amount of interest in identifying these cells. The breast is a complex tissue consisting of two epithelial layers (an outer myoepithelial/basal layer and an inner luminal epithelial layer) as well as a large non-epithelial component (fibroblasts, endothelial cells, lymphocytes, adipocytes, neurons and myocytes). The definitive identification of a mammary epithelial stem cell population is critically dependent on its purity. To date, this has been hampered by the lack of suitable markers to separate out the two epithelial layers, and to remove contaminating non-epithelial cells. Mouse mammary glands were dissociated and stained with CD24. Cells were sorted into separate populations based on CD24 expression and assessed for luminal epithelial and myoepithelial/basal markers by direct fluorescent microscopy and real time PCR. The stem/progenitor potential of these cell populations was assessed in vivo by cleared mammary fat pad transplantation. Three populations of CD24 expressing cells were identified: CD24Negative, CD24Low and CD24High. Staining of these cells with cytokeratin markers revealed that these populations correspond to non-epithelial, myoepithelial/basal and luminal epithelial cells, respectively. Cell identities were confirmed by quantitative PCR. Cleared mammary fat pad transplantation of these cell populations revealed that extensive mammary fat pad repopulation capacity segregates with the CD24Low cells, whilst CD24High cells have limited repopulation capacity. Differential staining of mammary epithelial cells for CD24 can be used to simultaneously isolate pure populations of non-epithelial, myoepithelial/basal and luminal epithelial cells. Furthermore, mammary fat pad repopulation capacity is enriched in the CD24Low population. As separation is achieved using a single marker, it will be possible to incorporate additional markers to further subdivide these populations. This will considerably facilitate the further analysis of mammary epithelial subpopulations, whilst ensuring high purity, which is key for understanding mammary epithelial stem cells in normal tissue biology and carcinogenesis.

MeSH Terms
Adipose Tissue Animals Biomarkers/analysis CD24 Antigen/analysis,biosynthesis Cell Transformation, Neoplastic Epithelial Cells Female Keratins/analysis Mammary Glands, Animal/cytology Mice Microscopy, Fluorescence Polymerase Chain Reaction Staining and Labeling Stem Cells
Chemicals
Biomarkers CD24 Antigen Keratins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sleeman Katherine E
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK. katherine.sleeman@icr.ac.uk
Kendrick Howard
Ashworth Alan
Isacke Clare M
Smalley Matthew J
References (14)
14 references, click to expand
  1. Stem cells and breast cancer: A field in transit.
    Nat Rev Cancer. 2003 Nov;3(11):832-44 PMID: 14668814
  2. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
    J Exp Med. 1996 Apr 1;183(4):1797-806 PMID: 8666936
  3. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype.
    Breast Cancer Res Treat. 1996;39(1):21-31 PMID: 8738603
  4. Clonal characterization of mouse mammary luminal epithelial and myoepithelial cells separated by fluorescence-activated cell sorting.
    In Vitro Cell Dev Biol Anim. 1998 Oct;34(9):711-21 PMID: 9794223
  5. Mammary epithelial stem cells: our current understanding.
    J Mammary Gland Biol Neoplasia. 1999 Jan;4(1):35-52 PMID: 10219905
  6. A putative human breast stem cell population is enriched for steroid receptor-positive cells.
    Dev Biol. 2005 Jan 15;277(2):443-56 PMID: 15617686
  7. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis.
    Proc Natl Acad Sci U S A. 2005 May 10;102(19):6942-7 PMID: 15860580
  8. Stem cells, cancer, and cancer stem cells.
    Nature. 2001 Nov 1;414(6859):105-11 PMID: 11689955
  9. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population.
    Dev Biol. 2002 May 1;245(1):42-56 PMID: 11969254
  10. Functional and molecular characterisation of mammary side population cells.
    Breast Cancer Res. 2003;5(1):R1-8 PMID: 12559051
  11. Prospective identification of tumorigenic breast cancer cells.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 PMID: 12629218
  12. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.
    Nat Med. 2005 Feb;11(2):127-9 PMID: 15685169
  13. The mammary gland "side population": a putative stem/progenitor cell marker?
    J Mammary Gland Biol Neoplasia. 2005 Jan;10(1):37-47 PMID: 15886885
  14. Reducing mammary cancer risk through premature stem cell senescence.
    Oncogene. 2001 Apr 26;20(18):2264-72 PMID: 11402321
Article Info
Journal
Breast cancer research : BCR
Abbr.
Breast Cancer Res
ISSN
1465-542X
Published
2006-00-00
Epub
2005-00-12
Pages
R7
Language
English
Region
England
NLM ID
100927353
PMCID
PMC1413978
Subset
IM
Grants
Breast Cancer Now · BREAST CANCER NOW RESEARCH CENTRE · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com